{"id":917214,"date":"2025-12-08T09:01:47","date_gmt":"2025-12-08T14:01:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/"},"modified":"2025-12-08T09:01:47","modified_gmt":"2025-12-08T14:01:47","slug":"beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/","title":{"rendered":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>IRVINE, Calif., Dec.  08, 2025  (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX) (the \u201cCompany\u201d), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026.<\/p>\n<p>Topline financial results covered in the pre-release are expected to include net sales, new patient starts, and the percentage of new patient starts reimbursed through the pharmacy benefit plan (PBP) channel.<\/p>\n<p>Members of the Company\u2019s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company invites investors to register for in-person meetings by contacting the Company\u2019s investor relations representative at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4KDVbo7BzjeXpA092-nBz3a4SPtvwWuE-1mJxVG-spHzsYBux7QxCO9Yd4kHYaPhmUk7mAd4Y-17DeEz76DSaC7rXPZsIIpKrq160QscX4Y=\" rel=\"nofollow\" target=\"_blank\">ir@betabionics.com<\/a>.<\/p>\n<p>\n        <strong>About Beta Bionics<\/strong>\n      <\/p>\n<p>Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AqY3dyiNqYBv2KFfPBE9XMgHCNTxQdEJ6bCzcfHKTizIPKWIGAM7VoRJZw5-N8qjjRc1ztl9QQH67BfBwh31p_kunDLAqKej6S26wnQn9js=\" rel=\"nofollow\" target=\"_blank\">www.betabionics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Blake Beber<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4KDVbo7BzjeXpA092-nBzxhC2J3hwPPLVwUraccLdXuoecEUib9ZRvyq_dlyu2gWzaQP-0_4BGNK-mdSxzS_r5NHZ0smI77dN82XVT4A8Kk=\" rel=\"nofollow\" target=\"_blank\"><strong>ir@betabionics.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media and Public Relations<\/strong>: <br \/>Karen Hynes<br \/>Vice President of Marketing<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l-IFeliK_ZKkns0jj8SMjyMF4EnxD50ldQhmGRKDnhpZOIIQqumxjopo66b4S0j4K07WmRzDokYYuWtx9rx4sEhAFfIy6FBiy4HBEaEx0jk=\" rel=\"nofollow\" target=\"_blank\"><strong>media@betabionics.com<\/strong><\/a><\/p>\n<p>Source:\u00a0Beta Bionics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODQ3YzJmNjAtZjE0ZC00ZGU2LWIwMGItNWZiY2QzMGM4ZWI2LTEyMTg5NDktMjAyNS0xMi0wOC1lbg==\/tiny\/Beta-Bionics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX) (the \u201cCompany\u201d), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026. Topline financial results covered in the pre-release are expected to include net sales, new patient starts, and the percentage of new patient starts reimbursed through the pharmacy benefit plan (PBP) channel. Members of the Company\u2019s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company invites investors to register for in-person meetings by contacting the Company\u2019s investor relations &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-917214","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX) (the \u201cCompany\u201d), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026. Topline financial results covered in the pre-release are expected to include net sales, new patient starts, and the percentage of new patient starts reimbursed through the pharmacy benefit plan (PBP) channel. Members of the Company\u2019s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company invites investors to register for in-person meetings by contacting the Company\u2019s investor relations &hellip; Continue reading &quot;Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-08T14:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026\",\"datePublished\":\"2025-12-08T14:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/\"},\"wordCount\":245,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/\",\"name\":\"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\",\"datePublished\":\"2025-12-08T14:01:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/","og_locale":"en_US","og_type":"article","og_title":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk","og_description":"IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) &#8212; Beta Bionics, Inc. (Nasdaq: BBNX) (the \u201cCompany\u201d), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026. Topline financial results covered in the pre-release are expected to include net sales, new patient starts, and the percentage of new patient starts reimbursed through the pharmacy benefit plan (PBP) channel. Members of the Company\u2019s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company invites investors to register for in-person meetings by contacting the Company\u2019s investor relations &hellip; Continue reading \"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-08T14:01:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026","datePublished":"2025-12-08T14:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/"},"wordCount":245,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/","name":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=","datePublished":"2025-12-08T14:01:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5Nzc4MiM3MzA3ODczIzIyMDczOTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beta-bionics-to-pre-announce-topline-fourth-quarter-2025-financial-results-the-week-of-january-5-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/917214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=917214"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/917214\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=917214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=917214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=917214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}